Screening for diabetes mellitus and humanimmunodefiency virus infection in personswith tuberculosis
PDF

Keywords

Diabetes mellitus
Tuberculosis
Screening
HIV

Abstract

Introduction. Nigeria is a country saddled with a high tubercu- losis (TB) and human immunodeficiency virus (HIV) burden but the possible combination of these communicable diseases with diabetes mellitus (DM) has been overlooked. We undertook to determine the burden of HIV and DM in persons with TB by docu- menting the prevalence rates of these disorders. Methods. This is a cross-sectional Study that was conducted within 54TB/DOT centers in Lagos State. A total of 3,376 persons with TB who were on antiTB drugs were screened for HIV and DM using standardized tests. Statistical analysis was performed using Students t test and chi square. Results. The frequency of occurrence of DM in TB and that of HIV in TB were comparable (4.8% Vs 3.5%). The Study subjects with DM were older, had higher waist circumference measure- ments and had higher proportions of hypertension compared to the subjects without DM. The combination of HIV and DM in TB was found in (0.3%). We also noted that DM in TB and HIV in TB occurred more frequently in the third and fourth decades of life. Conclusion. This study demonstrated the potential co existence of HIV, DM and Tuberculosis. It is therefore important that these two diseases are sought for in patients with TB considering the changing epidemiology of these diseases particularly in develop- ing countries like Nigeria.
https://doi.org/10.15167/2421-4248/jpmh2014.55.2.426
PDF

References

Zimmet P, Shaw J, Alberti KG. Preventing Type 2 Diabetes and the Dysmorphic syndrome in the real world: a realistic view. Diabet Med. 2003;20:693–702.

Akinkugbe OO, Akinyanju OO. Final Report-national Survey on non-communicable diseases in Nigeria. Lagos: Federal Ministry of Health; 1997. pp. 65–68.

www.unaids.org. HIV and AIDs Estimates, Nigeria.

Global Tuberculosis Report, 2012. Geneva: World Health Organization; 2012.

WHO , author. Global tuberculosis control: surveillance, planning, financing. WHO report 2005. Geneva: World Health Organisation; 2005.

Nigeria Tuberculosis Fact Sheet. Photos.state.gov.libraries/Nigeria/487468/pdfs/JanuaryTuberculosisFactSheets.pdf.

DeReimer K. Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics. Am J Respir Crit Care Med. 2007;176:936–936.

Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9:737–746.

Stop TB Initiative (World Health Organization); World Health Organization, Department of Chronic Diseases and Health Promotion; International Union against Tuberculosis and Lung Disease , author. Collaborative framework for care and control of tuberculosis and diabetes. Geneva: World Health Organization; 2011.

Li L, Lin Y, Mi F, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health. 2012;17:1294–1301.

Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One. 2012;7:e41367–e41367.

Balakrishnan S, Vijayan S, Nair S, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One. 2012;7:e46502–e46502.

Global Tuberculosis Report, 2012. Geneva: World Health Organization; 2012.

Young F, Critchley JA, Johnstone LK, et al. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health. 2009;5:9–9.

World Health Organization , author. Treatment of tuberculosis: guidelines for national program. Geneva: World Health Organization; 2006.

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , author. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197.

World Health Organization , author. Tuberculosis and HIV data and statistics. www.who.int/hiv/topics/tb/data/en/index1.html.

Bekkee L-G, Wood R. The changing natural history of Tuberculosis and HIV coinfection in an urban area of Hyperendemicity. Clin Infect Dis. 2010;50:S208–S214.

Odaibo GN, Gboun MF, Ekanem EE, et al. HIV infection among patients with pulmonary tuberculosis in Nigeria. Afr Med J Sci. 2006;35:S93–S98.

Mugusi F, Swai AB, Aberti KG, et al. Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle. 1990;71:271–276.

Ruslami R, Aarnoutse RE, Alisjahbana B, et al. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health. 2010;15:1289–1299.

Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L, et al. Association of diabetes and tuberculosis; impact on treatment and post-treatment outcomes. Thorax. doi:10.1136/thoraxjnl- 2012-201756.

Unadike BC, Eregie A, Ohwovoriole AE. Prevalence of hypertension amongst patients with diabetes mellitus in Benin City, Nigeria. Niger J Clin Pract. 2011;14:300–302.